Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urasaki, T.
Right arrow Articles by Ninomiya, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urasaki, T.
Right arrow Articles by Ninomiya, H.
(Journal of Leukocyte Biology. 2001;69:105-112.)
© 2001 by Society for Leukocyte Biology

Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway

Tetsuya Urasaki*, Jun Takasaki{dagger}, Toshiro Nagasawa* and Haruhiko Ninomiya{ddagger}

* Division of Hematology, Institute of Clinical Medicine, University of Tsukuba
{dagger} Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co., Ltd.
{ddagger} College of Medical Technology, University of Tsukuba, Japan

Correspondence: Haruhiko Ninomiya, M.D., Ph.D., College of Medical Technology, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki 305-8577, Japan. E-mail: hninomiya{at}itan.tsukuba.ac.jp

CD69 is an activation-related cell surface molecule on human eosinophils. It has been reported that interleukin (IL)-5, but not platelet-activating factor (PAF), can induce CD69 on human eosinophils in vitro. In this study, PAF induced CD69 intensely on eosinophils from patients with hypereosinophilic syndrome (HES), while only weakly on those from normal donors. Because HES eosinophils contain abundant cytosolic phospholipase A2 (cPLA2) and 5-lipoxygenase (5-LO), we examined the roles of several enzymes involved in the metabolism of arachidonic acid in the PAF- or IL-5-induced CD69 expression on eosinophils. The CD69 expression induced by PAF and IL-5 on HES eosinophils and that by IL-5 on normal eosinophils were both inhibited by AA861 and MK-886, inhibitors of 5-LO activity. In addition, AACOCF3, a selective cPLA2 inhibitor, inhibited IL-5-induced CD69 expression on normal eosinophils, although it hardly affected either IL-5- or PAF-induced CD69 expression on HES eosinophils. Moreover, PAF alone induced CD69 only weakly on normal eosinophils, but exogenous arachidonic acid remarkably enhanced PAF-induced CD69 expression on them. These findings suggest that IL-5 activates both cPLA2 and 5-LO but PAF activates only 5-LO. It is suggested that 5-LO plays a critical role in the induction of CD69 on eosinophils.

Key Words: hypereosinophilic syndrome • cytosolic phospholipase A2 • arachidonic acid




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Christmas, N. Carlesso, H. Shang, S.-M. Cheng, B. M. Weber, F. I. Preffer, D. T. Scadden, and R. J. Soberman
Myeloid Expression of Cytochrome P450 4F3 Is Determined by a Lineage-specific Alternative Promoter
J. Biol. Chem., June 27, 2003; 278(27): 25133 - 25142.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Bandeira-Melo, L. J. Woods, M. Phoofolo, and P. F. Weller
Intracrine Cysteinyl Leukotriene Receptor-mediated Signaling of Eosinophil Vesicular Transport-mediated Interleukin-4 Secretion
J. Exp. Med., September 16, 2002; 196(6): 841 - 850.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Leukocyte Biology.